APA (7th ed.) Citation

Cherkos, A. S., LaCourse, S. M., Enquobahrie, D. A., Escudero, J. N., Mecha, J., Matemo, D., . . . John-Stewart, G. (2024). Isoniazid preventive therapy during infancy does not adversely affect growth among HIV-exposed uninfected children: Secondary analysis of data from a randomized controlled trial. PLoS ONE, 19(8), 1. https://doi.org/10.1371/journal.pone.0293708

Chicago Style (17th ed.) Citation

Cherkos, Ashenafi Shumey, Sylvia M. LaCourse, Daniel A. Enquobahrie, Jaclyn N. Escudero, Jerphason Mecha, Daniel Matemo, John Kinuthia, Sarah J. Iribarren, and Grace John-Stewart. "Isoniazid Preventive Therapy During Infancy Does Not Adversely Affect Growth Among HIV-exposed Uninfected Children: Secondary Analysis of Data from a Randomized Controlled Trial." PLoS ONE 19, no. 8 (2024): 1. https://doi.org/10.1371/journal.pone.0293708.

MLA (9th ed.) Citation

Cherkos, Ashenafi Shumey, et al. "Isoniazid Preventive Therapy During Infancy Does Not Adversely Affect Growth Among HIV-exposed Uninfected Children: Secondary Analysis of Data from a Randomized Controlled Trial." PLoS ONE, vol. 19, no. 8, 2024, p. 1, https://doi.org/10.1371/journal.pone.0293708.